Sikpi M O, Waters L C, Kraemer K H, Preston R J, Mitra S
University of Tennessee Graduate School of Biomedical Sciences, Biology Division, Oak Ridge.
Mol Carcinog. 1990;3(1):30-6. doi: 10.1002/mc.2940030108.
The supF gene of the recombinant shuttle plasmid pZ190 (modified pZ189) was used as a target to study the nature of mutations induced by N-methyl-N-nitrosourea (MNU) in human cells. Treatment of the intact plasmid with MNU followed by its replication in human lymphoblastoid cells led to extensive inactivation and no detectable mutations of the plasmid. However, exposure of the supF DNA fragment alone, followed by its ligation into the vector, caused a ten-fold increase in mutant frequency when replicated in O6-methylguanine-DNA methyltransferase-deficient cells (from 0.54 x 10(-3) to 5.8 x 10(-3)) and an 80-fold increase when replicated in cells containing normal levels of the enzyme (from 0.047 x 10(-3) to 3.8 x 10(-3)). About 45% of the mutant plasmid molecules recovered from human cells contained deletions and insertions. Sixty to 70% of the mutant molecules of wild-type size contained a single-base substitution. Most of these changes were of the G.C----A.T type, consistent with the hypothesis that O6-methylguanine is the primary mutagenic adduct induced by MNU. However, the distribution of mutation sites was highly nonrandom; more than half of all mutations were localized at the G.C position 123, and the rest were distributed in about a dozen sites. The high yield of mutations induced in the supF DNA in a host cell whose capacity for the removal of O6-methylguanine far exceeded the amount present in the supF suggests that the repair of damages in extrachromosomal DNA may be inefficient. This is supported by the observation that the yield of mutations in supF transfected into lymphoblastoid cells devoid of repair activity for O6-methylguanine was comparable to that observed with repair-proficient host cells. The present data, together with results of mutations induced in pZ189 by other agents, strongly suggest that one major determinant of mutational hot spots is the structure of the target DNA itself.
重组穿梭质粒pZ190(改良型pZ189)的supF基因被用作研究N-甲基-N-亚硝基脲(MNU)在人细胞中诱导的突变性质的靶标。用MNU处理完整质粒,随后在人淋巴母细胞中复制,导致质粒大量失活且未检测到突变。然而,单独暴露supF DNA片段,随后将其连接到载体中,当在O6-甲基鸟嘌呤-DNA甲基转移酶缺陷型细胞中复制时,突变频率增加了10倍(从0.54×10⁻³增加到5.8×10⁻³),当在含有正常水平该酶的细胞中复制时,突变频率增加了80倍(从0.047×10⁻³增加到3.8×10⁻³)。从人细胞中回收的约45%的突变体质粒分子含有缺失和插入。野生型大小的突变分子中有60%至70%含有单碱基取代。这些变化大多是G.C→A.T类型,这与O6-甲基鸟嘌呤是MNU诱导的主要诱变加合物的假设一致。然而,突变位点的分布高度非随机;所有突变的一半以上位于G.C位置123,其余分布在大约十几个位点。在宿主细胞中,其去除O6-甲基鸟嘌呤的能力远远超过supF中存在的量,supF DNA中诱导的高突变率表明染色体外DNA损伤的修复可能效率低下。这一点得到以下观察结果的支持:将supF转染到对O[6]-甲基鸟嘌呤缺乏修复活性的淋巴母细胞中时,突变率与在具有修复能力的宿主细胞中观察到的相当。目前的数据,连同其他试剂在pZ189中诱导突变的结果,强烈表明突变热点的一个主要决定因素是靶标DNA本身的结构。